Clozapine Treatment Guidelines

Mechanism of Action and Efficacy

Clozapine has a complex mechanism of action involving multiple neurotransmitter systems, including antagonism of serotonergic receptors, and is considered the prototype of atypical antipsychotics, marking a significant advancement in the treatment of schizophrenia 1
It demonstrates efficacy for both positive and negative symptoms of schizophrenia, unlike many typical antipsychotics that primarily address positive symptoms 2

Clozapine is generally not used as a first-line agent due to its significant side effect profile, particularly the risk of agranulocytosis, and is typically reserved for treatment-resistant schizophrenia after therapeutic trials of at least two other antipsychotic medications have failed 1
The American Academy of Child and Adolescent Psychiatry recommends clozapine for treatment-resistant schizophrenia after therapeutic trials of at least two other antipsychotic medications have failed 1

Weekly white blood cell counts are mandatory during the first 6 months of treatment with clozapine, then every 2 weeks thereafter, due to the risk of agranulocytosis 3
Other significant side effects of clozapine include seizures, sedation, weight gain, hypersalivation, orthostatic hypotension, tachycardia, and fever 3, 4
The risk of seizures increases in a dose-dependent manner, particularly with rapid dosage increases 3